Sagamore Investments

Sagamore Investments is a fund of funds and private equity firm headquartered in Beijing, China. The firm specializes in direct investments and fund of funds, focusing on venture capital, growth capital, and late-stage private equity. It primarily targets high-growth sectors aligned with China's consumption upgrade, including fintech, healthcare, artificial intelligence, and education. Sagamore Investments typically seeks to take a majority stake in its direct investments, emphasizing its commitment to fostering growth in these dynamic industries within China.

Established in 2002, Sagamore Investments has built a reputation for its strategic approach to investing in sectors that are pivotal to China's economic development. The firm's investment strategy involves identifying and partnering with companies at inflection points in their development, where it can collaborate with management to accelerate growth and enhance future performance. This operationally driven investment perspective is supported by the expertise and deep industry knowledge of its principals, as well as a network of long-standing industry relationships.

Sagamore Investments' portfolio includes companies such as Stealth BioTherapeutics, a leader in the tactical computing and communication systems industry. The firm's approach is characterized by a focus on sectors that are integral to China's consumption upgrade, aiming to support and accelerate the growth of companies within these industries. By taking a majority stake in its direct investments, Sagamore Investments demonstrates its commitment to fostering growth and enhancing the future performance of its portfolio companies.